EU drug regulator reviewing 5 cases of NEW blood condition in AstraZeneca Covid vaccine recipients amid possible link to jab

Five cases of

Five cases of a very rare blood disorder in people who have received the Covid-19 vaccine developed by AstraZeneca are being reviewed by the European Medicines Agency (EMA), the EU’s drug regulator has said.

The cases of “capillary leak syndrome,” which can cause leakage of fluid from blood vessels, tissue swelling and a drop in blood pressure, were reported from across the European Economic Area, the EMA said on Friday.

Continue reading https://on.rt.com/b5pz